Cubist Pharmaceuticals, Inc. (CBST) Tops Q2 EPS by 23c
Tweet Send to a FriendGet Alerts CBST Hot Sheet
Price: $49.51 --0%
Revenue Growth %: +8.6%
Financial Fact:
(Benefit) provision for income taxes: -2.5M
Today's EPS Names:
CAMT, HAST, BABY, More
Revenue Growth %: +8.6%
Financial Fact:
(Benefit) provision for income taxes: -2.5M
Today's EPS Names:
CAMT, HAST, BABY, More
Trade CBST Now!
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) reported Q2 EPS of $0.68, $0.23 better than the analyst estimate of $0.45. Revenue for the quarter came in at $230.6 million versus the consensus estimate of $226.05 million.
For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Qihoo 360 Technology (QIHU) Reports In-Line Q1 EPS; Guides Q2 Sales
- Alvarion Ltd (ALVR) Narrows Q1 Loss
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
